<DOC>
<DOCNO>
EP-0000968
</DOCNO>
<TEXT>
<DATE>
19790307
</DATE>
<IPC-CLASSIFICATIONS>
A61P-31/00 <main>A61K-33/24</main> A61K-33/24 A61K-33/34 A61P-3/00 A61P-29/00 A61P-31/04 
</IPC-CLASSIFICATIONS>
<TITLE>
a pharmaceutical composition with an anti-infectious, anti-inflammatory and anti-asthenic effect.
</TITLE>
<APPLICANT>
lepeix liliane<sep>suck catherine genevieve<sep>lepeix, liliane<sep>suck, catherine genevieve<sep>lepeix, liliane7, rue théophile rousself-75012 parisfr <sep>suck, catherine geneviève10, rue emile morel f-92330 sceaux fr <sep>lepeix, liliane<sep>suck, catherine genevieve<sep>
</APPLICANT>
<INVENTOR>
lepeix liliane<sep>suck catherine genevieve<sep>lepeix, liliane<sep>suck, catherine genevieve<sep>lepeix, liliane7, rue théophile rousself-75012 parisfr<sep>suck, catherine geneviève10, rue emile morelf-92330 sceauxfr<sep>lepeix, liliane<sep>suck, catherine genevieve  <sep>lepeix, liliane 7, rue théophile rousself-75012 parisfr<sep>suck, catherine geneviève10, rue emile morelf-92330 sceauxfr<sep>
</INVENTOR>
<ABSTRACT>
1.  a pharmaceutical composition containing in 100 ml of an aqueous solution the following amounts : colloidal gold from 0,0003 to 0,0012 g manganese gluconate from 0,015 to 0,060 g copper gluconate from 0,015 to 0,060 g. 
</ABSTRACT>
</TEXT>
</DOC>
